Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis (Q43258430)

17 November 2017

Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis (English)

1 reference

17 November 2017

0 references

1 reference

1

1 reference

17 November 2017

4

Wim Laleman

0 references

author name string

Martin Hennenberg

2

1 reference

17 November 2017

Andrea Schulze Pröbsting

3

1 reference

17 November 2017

Wim Laleman

4

1 reference

17 November 2017

Sabine Klein

5

1 reference

17 November 2017

Michaela Granzow

6

1 reference

17 November 2017

Frederik Nevens

7

1 reference

17 November 2017

Johan Zaagsma

8

1 reference

17 November 2017

Jörg Heller

9

1 reference

17 November 2017

Tilman Sauerbruch

10

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

17 November 2017

1 reference

17 November 2017

50

1 reference

17 November 2017

6

1 reference

17 November 2017

1924-1935

1 reference

Liver microvascular architecture: an insight into the pathophysiology of portal hypertension

17 November 2017

1 reference

Mechanisms of extrahepatic vasodilation in portal hypertension.

21 January 2018

1 reference

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

21 January 2018

1 reference

Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats

21 January 2018

1 reference

Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats

21 January 2018

1 reference

Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis

21 January 2018

1 reference

Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis

21 January 2018

1 reference

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

21 January 2018

1 reference

The brown adipocyte beta-adrenoceptor

21 January 2018

1 reference

Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta 3-adrenoceptor'?

21 January 2018

1 reference

Functional beta3-adrenoceptor in the human heart

21 January 2018

1 reference

Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium

21 January 2018

1 reference

Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure

21 January 2018

1 reference

Characterization of beta 3-adrenoceptor-mediated relaxation in rat abdominal aorta smooth muscle

21 January 2018

1 reference

Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway

21 January 2018

1 reference

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

21 January 2018

1 reference

Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins

21 January 2018

1 reference

The beta-adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the beta 3-, but also of the beta 2-subtype

21 January 2018

1 reference

Differential recruitment and differential regulation by physiological amines of fat cell beta-1, beta-2 and beta-3 adrenergic receptors expressed in native fat cells and in transfected cell lines

21 January 2018

1 reference

Regulation of beta 3-adrenoceptor expression in white fat cells

21 January 2018

1 reference

Relationship between lipolysis and cyclic AMP generation mediated by atypical beta-adrenoceptors in rat adipocytes

21 January 2018

1 reference

Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway

21 January 2018

1 reference

Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice

21 January 2018

1 reference

Characterization of beta3-adrenoceptors in human internal mammary artery and putative involvement in coronary artery bypass management

21 January 2018

1 reference

Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function

21 January 2018

1 reference

Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells

21 January 2018

1 reference

Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

21 January 2018

1 reference

Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery

21 January 2018

1 reference

Tools to study beta3-adrenoceptors

21 January 2018

1 reference

Chapter 4 Preparation of Isolated Rat Liver Cells

21 January 2018

1 reference

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow

21 January 2018

1 reference

Modulation of agonist-induced phosphoinositide metabolism, Ca2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms

21 January 2018

1 reference

21 January 2018

1 reference

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta

21 January 2018

1 reference

Reduced beta 1 receptor messenger RNA abundance in the failing human heart

21 January 2018

1 reference

Hepatic fibrogenesis requires sympathetic neurotransmitters

21 January 2018

1 reference

Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells.

21 January 2018

1 reference

Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats

21 January 2018

1 reference

Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins

21 January 2018

1 reference

7 January 2021

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

1 reference

7 January 2021

Differential interaction of beta 1- and beta 3-adrenergic receptors with Gi in rat adipocytes

1 reference

7 January 2021

Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats

1 reference

7 January 2021

Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine

1 reference

7 January 2021

Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23222

1 reference

17 November 2017

1 reference